Saccharomyces cerevisiae strain UFMG 905 protects against bacterial translocation, preserves gut barrier integrity and stimulates the immune system in a murine intestinal obstruction model
- 445 Downloads
Probiotic is a preparation containing microorganisms that confers beneficial effect to the host. This work assessed whether oral treatment with viable or heat-killed yeast Saccharomyces cerevisiae strain UFMG 905 prevents bacterial translocation (BT), intestinal barrier integrity, and stimulates the immunity, in a murine intestinal obstruction (IO) model. Four groups of mice were used: mice undergoing only laparotomy (CTL), undergoing intestinal obstruction (IO) and undergoing intestinal obstruction after previous treatment with viable or heat-killed yeast. BT, determined as uptake of 99mTc-E. coli in blood, mesenteric lymph nodes, liver, spleen and lungs, was significantly higher in IO group than in CTL group. Treatments with both yeasts reduced BT in blood and all organs investigated. The treatment with both yeasts also reduced intestinal permeability as determined by blood uptake of 99mTc-DTPA. Immunological data demonstrated that both treatments were able to significantly increase IL-10 levels, but only viable yeast had the same effect on sIgA levels. Intestinal lesions were more severe in IO group when compared to CTL and yeasts groups. Concluding, both viable and heat-killed cells of yeast prevent BT, probably by immunomodulation and by maintaining gut barrier integrity. Only the stimulation of IgA production seems to depend on the yeast viability.
KeywordsProbiotic Bacterial translocation Intestinal permeability Intestinal obstruction sIgA IL-10
The study was supported by grants from Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG) and Conselho Nacional de Pesquisa (CNPq). The authors thank Dr. Carlos A. Rosa for providing the yeast S. cerevisiae 905.
- Ciriello CJ, Lachance MA (2001) YEASTCOMPARE. University of Western Ontario, LondonGoogle Scholar
- Dalmasso D, Loubat A, Dahan S, Calle G, Rampal P, Czerucka D (2006) Saccharomyces boulardii prevents TNF-α induced apoptosis in EHEC-infected T84 cells. Res Microbiol 55:1–10Google Scholar
- FAO/WHO Report (2002) Food and Agricultural Organization/World Health Organization Working Group. Guidelines for the evaluation of probiotics in food, London, Ontario, Canada, April 30 and May 1Google Scholar
- Geyik MF, Aldemir M, Hosoglu S, Ayaz C, Satilmis S, Buyukbayram H, Kokoglu OF (2006) The effects of Saccharomyces boulardii on bacterial translocation in rats with obstruction jaundice. Ann Rev Coll Surg Engl 88:178–180Google Scholar
- Imaoka A, Shima T, Kato K, Mizuno S, Uehara T, Matsumoto S, Hara ST, Umesaki Y (2008) Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells. World J Gastroenterol 16:2511–2516CrossRefGoogle Scholar
- Martins FS, Rodrigues ACP, Tiago FCP, Penna FJ, Rosa CA, Arantes RME, Nardi RMD, Neves MJ, Nicoli JR (2007) Saccharomyces cerevisiae strain 905 reduces the translocation of Salmonella enterica serotype Typhimurium and stimulates the immune system in gnotobiotic and conventional mice. J Med Microbiol 56:352–359CrossRefPubMedGoogle Scholar
- National Research Council (1996) Guide for the care and use of laboratory animals. National Academy Press, WashingtonGoogle Scholar
- Tannock G (2005) Probiotics and prebiotics: scientific aspects, 1st edn. Caister Academic Press, University of Otago, DunedinGoogle Scholar